Search Results - "Spalek, Adrianna"
-
1
Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience
Published in International journal of hematology (01-12-2022)“…Steroid-refractory acute graft-versus-host disease (SR-aGVHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic stem cell…”
Get full text
Journal Article -
2
Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
Published in Medicina (Kaunas, Lithuania) (24-11-2022)“…Chronic graft-versus-host disease (cGVHD) is a serious complication after allogenic hematopoietic stem cell transplantation (allo-HSCT), negatively affecting…”
Get full text
Journal Article -
3
Ruxolitinib is highly effective in steroid-resistant graft-versus-host disease: real-world data from a single center
Published in Polskie archiwum medycyny wewne̦trznej (29-03-2023)Get more information
Journal Article -
4
Allogeneic hematopoietic stem cell transplantation for relapsed B‑cell acute lymphoblastic leukemia after failure of autologous hematopoietic stem cell transplantation: a retrospective single-center analysis
Published in Polskie archiwum medycyny wewne̦trznej (30-03-2022)Get more information
Journal Article -
5
Cardiomyopathy development protection after myocardial infarction in rats: Successful competition for major dihydropyridines' common metabolite against captopril
Published in PloS one (21-06-2017)“…During the last 25 years angiotensin-converting enzyme inhibitors spectacularly conquered the field of cardiovascular diseases therapy. Nevertheless, lack of…”
Get full text
Journal Article -
6
Room for Improvement: A 20-Year Single Center Experience with Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes
Published in Indian journal of hematology & blood transfusion (01-10-2022)“…Allogeneic stem cell transplantation (allo-SCT) remains the only curative therapeutic approach for patients with myelodysplastic syndromes (MDS). The aim of…”
Get full text
Journal Article -
7
Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: A Single-Centre Experience
Published in Clinical lymphoma, myeloma and leukemia (01-01-2023)“…Patients with relapsed/refractory acute myeloid leukemia (r/r AML) are characterized as having a poor prognosis. The only viable option of treatment for these…”
Get full text
Journal Article -
8
Dihydropyridines’ metabolites-induced early apoptosis after myocardial infarction in rats; new outlook on preclinical study with M-2 and M-3
Published in Apoptosis (London) (01-02-2016)“…Our previous studies established cardio-protective effects of furnidipine and its active metabolites called M-2 and M-3. The aim of current research was to…”
Get full text
Journal Article -
9
Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis
Published in Clinical rheumatology (01-06-2018)“…Autologous hematopoietic stem cell transplantation (AHSCT) is thought to be effective therapeutic approach in patients with poor prognosis systemic sclerosis;…”
Get full text
Journal Article -
10
Impact of Cytoreductive Drugs upon Outcomes in a Contemporary Cohort of Adolescent and Young Adults with Essential Thrombocythemia and Polycythemia Vera
Published in Blood (02-11-2023)“…Introduction Essential thrombocythemia (ET) and polycythemia vera (PV) are well described in adolescent and young adults (AYA) patients (pts); the most…”
Get full text
Journal Article -
11
Myeloproliferative Neoplasms in Patients below 25 Years Old at Diagnosis: A Retrospective International Cooperative Work
Published in Blood (29-11-2018)“…Myeloproliferative neoplasms (MPN) are most common in old people (>60 years) and are rarely identified in children and young adults where information about…”
Get full text
Journal Article -
12
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs
Published in Blood advances (13-09-2022)“…Myeloproliferative neoplasms (MPNs) are uncommon in children/young adults. Here, we present data on unselected patients diagnosed before 25 years of age…”
Get full text
Journal Article -
13
-
14
Fatal outcome of a rare acute myeloid leukemia with t(8;16)(p11.2;p13.3) and KAT6A::CREBBP gene fusion in a young man
Published in Hematology, transfusion and cell therapy (01-04-2024)Get full text
Journal Article -
15
Ruxolitinib for steroid-refractory acute graft versus host disease: case series and literature review
Published in Acta haematologica polonica (25-02-2022)Get full text
Journal Article -
16
Allogeneic transplantation for high-risk chronic lymphocytic leukemia—a summary of a 16-year experience
Published in Annals of hematology (01-06-2019)“…In the pathway inhibitor era, the number of allogeneic stem cell transplantation (ASCT) for chronic lymphocytic leukemia (CLL) continues to decrease and this…”
Get full text
Journal Article -
17
Allogeneic stem cell transplantation remains an effective therapeutic approach for patients with therapy-related acute myeloid leukemia
Published in Acta haematologica polonica (29-04-2021)Get full text
Journal Article -
18
-
19
-
20